Varex director converts 8,483 units to stock

Varex Imaging Corp director Jocelyn D. Chertoff reported the conversion of 8,483 Deferred Stock Units into 8,483 shares of common stock on February 9, 2026, at an exercise price of $0 per unit.

Rhea-AI Filing Summary

Varex Imaging Corp director Jocelyn D. Chertoff reported the conversion of 8,483 Deferred Stock Units into 8,483 shares of common stock on February 9, 2026, at an exercise price of $0 per unit.

The footnotes state these Deferred Stock Units were granted on February 9, 2023, vested on February 8, 2024, and were delivered in stock on the third anniversary of the grant date. Following this settlement, Chertoff directly holds 42,194 shares of Varex Imaging common stock and no remaining Deferred Stock Units from this grant.

Insider Trade Summary

8,483 shares exercised/converted

Exercise 2 txns

Insider Chertoff Jocelyn D

Role Director

Type	Security	Shares	Price	Value
Exercise	Deferred Stock Units	8,483	$0.00	$0.00
Exercise	Common Stock	8,483	$0.00	$0.00

Holdings After Transaction: Deferred Stock Units — 0 contracts (Direct); Common Stock — 42,194 shares (Direct)

Footnotes (2)

1. F1. Each Deferred Stock Unit converts into common stock on a one-for-one basis.
2. F2. These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Varex Imaging (VREX) report for Jocelyn D. Chertoff?

Varex Imaging director Jocelyn D. Chertoff converted 8,483 Deferred Stock Units into 8,483 shares of common stock. The transaction occurred on February 9, 2026, at an exercise price of $0 per unit, reflecting settlement of a prior equity award.

How many Varex Imaging (VREX) shares does Jocelyn D. Chertoff own after this Form 4?

After the reported transaction, Jocelyn D. Chertoff directly owns 42,194 shares of Varex Imaging common stock. This total reflects the addition of 8,483 shares delivered upon conversion of previously granted Deferred Stock Units on February 9, 2026.

What does the Deferred Stock Unit conversion mean in the VREX Form 4?

The conversion means 8,483 Deferred Stock Units were exchanged one-for-one for 8,483 Varex Imaging common shares. The units were granted in 2023, vested in 2024, and were delivered as stock on February 9, 2026, with no cash exercise price.

When were the Deferred Stock Units in the Varex Imaging (VREX) filing granted and vested?

The Deferred Stock Units were granted on February 9, 2023, and vested on February 8, 2024. Delivery of the vested units in the form of Varex Imaging common stock occurred on February 9, 2026, the third anniversary of the original grant date.

Is the Varex Imaging (VREX) Form 4 transaction a market purchase or sale?

No, the Form 4 shows an award settlement, not an open-market trade. Deferred Stock Units converted into common stock at a $0 exercise price, reflecting delivery of a previously granted director equity award rather than a cash purchase or sale.

What role does Jocelyn D. Chertoff hold at Varex Imaging (VREX)?

Jocelyn D. Chertoff is identified as a director of Varex Imaging Corp. The Form 4 reports her receipt of common shares through the conversion of previously granted Deferred Stock Units, a form of director equity compensation that settled in stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chertoff Jocelyn D

(Last) (First) (Middle)

C/O VAREX IMAGING CORP.

1678 S. PIONEER ROAD

(Street)

SALT LAKE CITY UT 84104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		M		8,483	A	(1)	42,194	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	02/09/2026		M			8,483	(2)	(2)	Common Stock	8,483	$0	0	D

Explanation of Responses:

1. Each Deferred Stock Unit converts into common stock on a one-for-one basis.

2. These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

Remarks:

	/s/ Jocelyn D. Chertoff	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.